Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10308485 | Seizure | 2014 | 6 Pages |
Abstract
NCSE in brain tumor patients may be under diagnosed due to the frequent lack of outward manifestations and highly treatable with improvement in the majority of patients. NCSE patients with progressing brain lesions, tumor recurrence, or metastatic disease are at serious risk of mortality within 2 months. Continuous EEG monitoring in brain tumor patients with recent clinical seizures and/or a depressed level of consciousness may be critical in providing appropriate care.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Lara V. Marcuse, Guido Lancman, Alexis Demopoulos, Madeline Fields,